milgamma® 300 mg vitamin B1 + 100 mg vitamin B6, 30 pcs

Milgamma 300 mg film-coated tablets: For neuropathies

Milgamma 300 mg film-coated tablets contains the active ingredients benfotiamine and vitamin B6, which are essential for nerve cells.These nutrients are necessary for the conversion of sugar into energy and the functioning of nerves.The combination of these active ingredients helps to counteract an undersupply of the nerve cells with these vitamins and is used in the treatment of neurological systemic diseases.The preparation is used for neurological systemic diseases caused by a deficiency of vitamins B1 and B6.No prescription is required for this product.

Mode of action

If diabetes is not adequately controlled, it can lead to secondary diseases such as vascular, nerve and kidney damage.Sensitivity and blood circulation in the extremities decrease, although this process occurs gradually and is often not noticed in time.Milgamma 300 mg film-coated tablets can help protect against these diseases.The preparation also contains benfotiamine, which prevents the accumulation of metabolic end products and thus prevents damage.

Active ingredients and ingredients

Each tablet of Milgamma 300 mg film-coated tablets contains 300 mg benfotiamine and 100 mg pyridoxine hydrochloride.Other ingredients include microcrystalline cellulose, cellulose powder, corn starch, gelatin, magnesium stearate, hypromellose, propylene glycol, titanium dioxide, black iron (III) oxide hydrate, talc and macrogol 6000.

Contraindications

Milgamma 300 mg film-coated tablets should not be taken if there is hypersensitivity to benfotiamine, thiamine, pyridoxine hydrochloride or any of the other ingredients.Neuropathies may occur if taken for more than six months.In such cases, the product should only be taken under medical supervision.

Dosage and intake

The usual dosage is one film-coated tablet once a day, which should be taken with sufficient fluid.The time of administration can be chosen arbitrarily.In acute cases, the dose can be increased to up to one film-coated tablet three times a day after consulting a doctor.Care should be taken not to exceed the dose indicated in the package leaflet to avoid overdose.

Patient information

Particular caution is required when taking the drug beyond six months as neuropathy may occur.There is no information about the use of the drug in children and older people.No special precautions are required when driving or using machines.

Pregnancy and breastfeeding

During pregnancy and breastfeeding, Milgamma 300 mg film-coated tablets should only be used to treat a proven vitamin B1 and B6 deficiency if the treating doctor considers this to be absolutely necessary.The recommended daily intake of vitamin B1 and B6 during pregnancy and breastfeeding should be observed.The safety of using doses higher than the daily recommended dose has not been established.

Notes

Milgamma 300 mg film-coated tablets is well tolerated, lactose-free and gluten-free.It is suitable for diabetics.The preparation is used to treat neurological systemic diseases caused by a deficiency of vitamins B1 and B6.